Recent news on Voriconazole

Committee for Medicinal Products for Human Use Post-Authorisation ...  -  25 May 2007
PharmaLive.com (press release),The contra-indication between efavirenz and voriconazole was removed since a recommendation on dose adjustments was agreed by the CHMP.

Multiple-Triazole–Resistant Aspergillosis  -  Apr 4, 2007
New England Journal of Medicine (subscription),To the Editor: The use of voriconazole has become common for the management of invasive aspergillosis. However, therapy with voriconazole still sometimes

It's Not Too Late  -  Apr 20, 2007
Kommersant,In addition, the boy will need to be treated with caspofungin and voriconazole for the fungus, at a cost of 496600 rubles.

Broadway Actress/HIV Advocate, Sheryl Lee Ralph, Unveils Winning ...  -  Apr 16, 2007
Drug Newswire (press release),Viagra(R) (sildenafil citrate), Levitra(R) (vardenafil HCl), Cialis(R) (tadalafil), Vfend(R) (voriconazole), Advair(R) (fluticasone propionate and

Posaconazole successful in treating fluconazole- and itraconazole ...  -  Feb 15, 2007
Aidsmap,Alternative treatments include itraconazole and voriconazole (which may be hampered by cross-resistance and drug interactions), and the more highly toxic

Merck & Co., Inc. To Distribute ATRIPLA™ in Developing Countries  -  Feb 16, 2007
WebWire (press release),Coadministration with astemizole, cisapride, midazolam, triazolam, ergot derivatives, or voriconazole is contraindicated. Concomitant use of efavirenz and

Gastrointestinal Medications  -  Jan 5, 2007
Psychosomatics (subscription)Wood N, Tan K, Purkins L, et al: Effect of omeprazole on the steady-state pharmacokinetics of voriconazole. Br J Clin Pharmacol 2003;

Walsh still not disclosing conflicts?  -  Dec 29, 2006
Scientist,Pfizer's drug, voriconazole, is mentioned in the abstract's conclusion, because the present study was carried out before posaconazole was introduced,

Injectable antipsychotic drug delivered by Captisol technology  -  Dec 20, 2006
DrugResearcher.com,...in the US: Pfizer's antifungal Vfend (voriconazole) and schizophrenia treatment Geodon (ziprasidone) and Bristol-Myers Squibb's Abilify (aripiprazole).

Basilea Announces Start of Phase III Program for Isavuconazole ...  -  Dec 20, 2006
PipelineReview.com (press release),The first protocol is a phase III, double-blind, randomized study to evaluate the safety and efficacy of isavuconazole (BAL8557) versus voriconazole for the

Basilea begins phase III fungal drug program  -  Dec 19, 2006
Pharmaceutical Business ReviewIn the program, the first protocol is a phase III study to evaluate the safety and efficacy of isavuconazole versus voriconazole for the primary treatment

Pharma Sector: Few Newsmakers Of The Week - Bristol-Myers, Glaxo ...  -  Dec 23, 2006
Trading Markets,The first phase III study is designed to evaluate the safety and efficacy of isavuconazole versus Pfizer's voriconazole for the primary treatment of

Pharma Sector: Few Newsmakers Of The Week - Bristol-Myers, Glaxo ...  -  Dec 23, 2006
Trading Markets,The first phase III study is designed to evaluate the safety and efficacy of isavuconazole versus Pfizer's voriconazole for the primary treatment of

Injectable antipsychotic drug delivered by Captisol technology  -  Dec 20, 2006
DrugResearcher.com,...in the US: Pfizer's antifungal Vfend (voriconazole) and schizophrenia treatment Geodon (ziprasidone) and Bristol-Myers Squibb's Abilify (aripiprazole).

Basilea Announces Start of Phase III Program for Isavuconazole ...  -  Dec 20, 2006
PipelineReview.com (press release),The first protocol is a phase III, double-blind, randomized study to evaluate the safety and efficacy of isavuconazole (BAL8557) versus voriconazole for the

Basilea begins phase III fungal drug program  -  Dec 19, 2006
Pharmaceutical Business ReviewIn the program, the first protocol is a phase III study to evaluate the safety and efficacy of isavuconazole versus voriconazole for the primary treatment

96-Week Data From Gilead’s Study 934 Comparing Viread ® and ...  -  Dec 15, 2006
Business Wire (press release),ATRIPLA is contraindicated for use with astemizole, cisapride, midazolam, triazolam, ergot derivatives, or voriconazole. Concomitant use of ATRIPLA and St.

Bristol-Myers Squibb, Gilead Sciences And Merck & Co. Submit ...  Oct 10, 2006
Coadministration of ATRIPLA with astemizole, cisapride, midazolam, triazolam, ergot derivatives, or voriconazole is contraindicated. ... -Medical News Today (press release), FDA Approves REYATAZ® (atazanavir Sulfate) 300 Mg Single Capsule ...  Oct 23, 2006
Propulsid® (cisapride), Versed® (midazolam), Halcion® (triazolam), ergot medicines (for example, Wigraine® and Cafergot®), or Vfend® (voriconazole). ... -Medical News Today (press release), FDA Approves REYATAZ(R) (atazanavir sulfate) 300 mg Single Capsule ...  Oct 20, 2006
Propulsid(R) (cisapride), Versed(R) (midazolam), Halcion(R) (triazolam), ergot medicines (for example, Wigraine(R) and Cafergot(R)), or Vfend(R) (voriconazole ... -PR Newswire (press release), Schering-Plough: new fungicide gets US approval  Sep 20, 2006
Pfizer's follow-up drug, Vfend (voriconazole), launched in 2002, is showing slow growth, but the Manhattan-based drug giant has been unable to maintain its ... -Pharmaceutical Business Review

Gilead Sciences en Merck sluiten overeenkomst voor distributie ...  Aug 11, 2006
ATRIPLA is contraindicated for use with astemizole, cisapride, midazolam, triazolam, ergot derivatives, or voriconazole. Concomitant use of ATRIPLA and St. ... -Netherlands Corporate News (persbericht)

FDA Approves ATRIPLA(TM), the First Once-Daily Single Tablet ...  Jul 20, 2006
ATRIPLA is contraindicated for use with astemizole, cisapride, midazolam, triazolam, ergot derivatives, or voriconazole. Concomitant use of ATRIPLA and St. ... -dBusinessNews Newark

Basilea Presents Compelling Clinical and Preclinical Data on Its ...  Jun 26, 2006
BAL4815, the active principle of BAL8557, displayed consistent activity against a large collection of voriconazole-resistant zygomycetes. ... -PrimeZone

Once-a Day Triple Drug Combination Approved For HIV  Jul 12, 2006
...in patients suffering from Hepatitis B infection and also in patients taking astemizole, cisapride, midazolam, triazolam, ergot derivatives, or voriconazole. ... -Food Consumer



Fungal prosthetic mitral valve endocarditis caused by ...  May 9, 2006
...as S brevicaulis and demonstrated mean inhibitory concentrations of 4 µg/mL to amphotericin B, 1 µg/mL to terbinafine, 8 µg/mL to voriconazole, and greater ... - The Journal of Thoracic and Cardiovascular Surgery

Bristol-Myers Squibb and Gilead Sciences Submit New Drug ...  Apr 27, 2006
Propulsid(R) (cisapride), Versed(R) (midazolam), Halcion(R) (triazolam), ergot medicines (for example, Wigraine(R) and Cafergot(R)), or Vfend(R) (voriconazole ... - International News Service

Bristol-Myers Squibb  Apr 27, 2006
Propulsid® (cisapride), Versed® (midazolam), Halcion® (triazolam), ergot medicines (for example, Wigraine® and Cafergot®), or Vfend® (voriconazole). ... - WebWire





Amphotericin B the First Antifungal Drug Approved by the US is ...  Mar 14, 2006
Overall, the antifungal therapeutic market has been stagnating since the introduction of caspofungin (Mercks Cancidas) and voriconazole (Pfizers Vfend), both ... - Genetic Engineering News



New Pfizer antifungal cleared in USA  Feb 22, 2006
Along with Vfend (voriconazole), introduced in 2002, Eraxis will help Pfizer inject some new vigour into its antifungal franchise, which was hit by the patent ... - Pharma Times (subscription),

TWO APPROACHES TO TREATMENT OF COMPLICATED CANDIDA GLABRATA ...  Jan 25, 2006
...due to C. glabrata. This patient failed to eradicate the organism after repeated courses of voriconazole. DISCUSSION: UTI caused ... - The Journal of Pharmacy Technology

Read the factors that are changing the Antifungals Market today ...  Jan 25, 2006
Overall, the antifungal therapeutic market has been stagnating since the introduction of caspofungin (Mercks Cancidas) and voriconazole (Pfizers Vfend), both ... - Business Wire

Bristol-Myers Squibb and Gilead Announce Data Supporting ...  Jan 9, 2006
Propulsid(R) (cisapride), Versed(R)(midazolam), Halcion(R) (triazolam), ergot medicines (for example,Wigraine(R) and Cafergot(R)), or Vfend(R) (voriconazole). ... - Finanzen.net

Companies Anticipate Filing New Drug Application in Second Quarter ...  Jan 9, 2006
Propulsid® (cisapride), Versed® (midazolam), Halcion® (triazolam), ergot medicines (for example, Wigraine® and Cafergot®), or Vfend® (voriconazole). ... - Nieuwsbank (persbericht)

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional